Who Has The Johnson And Johnson Vaccine
Share
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Been Approved For
The Johnson & Johnson COVID-19 vaccine has been approved for emergency use by the U.S. Food and Drug Administration (FDA) for use in individuals 18 years and older. This one-dose vaccine offers protection from the most common coronavirus variants while also providing an easier administration as compared to the two-dose vaccines from Moderna and Pfizer. The vaccine has been tested in people of various backgrounds and in many countries around the world, with encouraging results.
The Johnson & Johnson vaccine is especially appealing to those individuals who are unable or unwilling to receive a second shot, as they only need a single dose, rather than the two required with the other vaccines. It also has the convenience of not requiring ultra-cold storage or transportation, thus freeing up resources for those who may have difficulty accessing the two-dose vaccine.
The FDA’s approval has thrust the Johnson & Johnson vaccine to the forefront of the fight against the COVID-19 pandemic, with notable plans for making the vaccine more readily available to an even wider demographic. This includes an agreement between the company and the White House to distribute an additional 16 million doses from their existing domestic supply, establishing one of the largest COVID-19 vaccine distribution efforts yet.
The Johnson and Johnson vaccine is now available to the U.S. population aged 18 and older and is provided at no cost. It is an important step forward and another effective tool in the fight against the virus.